Organization Overview
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
albumin (Human) (Plasbumin) (1 trial)
asparaginase (elspar) (7 trials)
atazanavir (reyataz) (1 trial)
azithromycin (zithromax) (1 trial)
bevacizumab (avastin) (4 trials)
chlorhexidine (hibitane) (1 trial)
cladribine (leustatin) (3 trials)
cytarabine (cytosar-u) (16 trials)
daunorubicin (cerubidine) (8 trials)
doxorubicin (Doxil) (12 trials)
doxycycline (vibramycin) (1 trial)
estradiol (progynon depot) (1 trial)
etoposide (vepesid) (9 trials)
fludarabine (fludara) (5 trials)
galantamine (reminyl) (1 trial)
idarubicin (idamycin) (8 trials)
lactobacillus rhamnosus (1 trial)
mercaptopurine (purinethol) (9 trials)
mitoxantrone (novantrone) (3 trials)
naltrexone (revia) (11 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)
prednisone (meticorten) (10 trials)
adapalene (differin) (1 trial)
allogeneic adipose derived mesenchymal stem cell (3 trials)
allopurinol (zyloprim) (1 trial)
amiodarone (cordarone) (1 trial)
bone marrow derived mesenchymal stem cells (1 trial)
C1 Esterase Inhibitor (Human) (Cinryze) (1 trial)
capecitabine (xeloda) (3 trials)
carboplatin (paraplatin) (2 trials)
cisplatin (platinol) (6 trials)
docetaxel (taxotere) (10 trials)
ferric carboxymaltose (Injectafer) (3 trials)
fluorouracil (efudex) (15 trials)
gemcitabine (gemzar) (2 trials)
house dust mite allergen (2 trials)
nelarabine (arranon) (2 trials)
oxaliplatin (eloxatin) (14 trials)
panobinostat (farydak) (2 trials)
pantoprazole (protonix) (1 trial)
pegaspargase (oncaspar) (1 trial)
pertuzumab (perjeta) (1 trial)
prednisolone (hydeltra) (1 trial)
aflibercept (zaltrap) (1 trial)
alemtuzumab (campath) (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
apremilast (otezla) (2 trials)
atezolizumab (Tecentriq) (1 trial)
autologous hematopoietic stem cells (1 trial)
berotralstat (Orladeyo) (1 trial)
betamethasone (celestone) (1 trial)
betrixaban (bevyxxa) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
calcipotriene (dovonex) (1 trial)
cytokine induced killer cells (1 trial)
dexrazoxane (zinecard) (1 trial)
durvalumab (imfinzi) (3 trials)
fluticasone (cutivate) (1 trial)
inotuzumab ozogamicin (besponsa) (1 trial)
intracoronary infusion of progenitor cells (1 trial)
montelukast (singulair) (1 trial)
olaratumab (lartruvo) (1 trial)
osimertinib (tagrisso) (1 trial)
pegylated arginine deiminase (1 trial)
Acne Conglobata (Phase 2)
Acne Vulgaris (Phase 3)
Acute Disease (Phase 2)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Clear Cell (Phase 3)
Adenomyoepithelioma (Phase 3)
Alzheimer Disease (Phase 4)
Anemia (Phase 3)
Anemia, Iron-Deficiency (Phase 3)
Anemia, Refractory (Phase 3)
Angioedema (Phase 3)
Angioedemas, Hereditary (Phase 3)
Anus Neoplasms (Phase 2)
Arthritis (Phase 4)
Arthritis, Psoriatic (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Asthma (Phase 4)
Ataxia (Phase 4)
Ataxia Telangiectasia (Phase 4)
Atrial Fibrillation (Phase 3)
Atrial Remodeling (Phase 3)
Bacterial Infections (Phase 4)
Biliary Tract Neoplasms (Phase 3)
Blast Crisis (Phase 2)
Breast Neoplasms (Phase 3)
Burkitt Lymphoma (Phase 4)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 1)
Cerebellar Ataxia (Phase 4)
Cholangiocarcinoma (Phase 2)
Cholangitis (Phase 4)
Colorectal Neoplasms (Phase 3)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 2)
Cystic Fibrosis (Phase 4)
Deficiency Diseases (Phase 3)
Delirium (Phase 3)
Dermatitis (Phase 1)
Dermatitis, Atopic (Phase 1)
Diabetes Mellitus (Phase 3)
Diabetic Retinopathy (Phase 3)
Eczema (Phase 1)
Emergencies (Phase 3)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 2)
Failure to Thrive (Phase 4)
Fallopian Tube Neoplasms (Phase 3)
Fibrosis (Phase 4)
Gallbladder Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 1)
Glioblastoma (Phase 3)
Granuloma (Phase 2)
Granulomatous Disease, Chronic (Phase 2)
Heart Diseases (Phase 2)
Heart Failure (Phase 3)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis C (Phase 4)
Hepatitis C, Chronic (Phase 2)
Humeral Fractures (Phase 2)
Hypersensitivity (Phase 3)
Hypertension (Phase 3)
Hyperuricemia (Phase 3)
Infarction (Phase 3)
Infections (Phase 4)
Inflammation (Phase 3)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Liver Diseases (Phase 4)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Macular Degeneration (Phase 4)
Macular Edema (Phase 3)
Mediastinal Neoplasms (Phase 4)
Melanoma (Phase 2)
Mesothelioma (Phase 2)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Myelodysplastic Syndromes (Phase 3)
Myocardial Infarction (Phase 3)
Myocardial Ischemia (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 2)
Neovascularization, Pathologic (Phase 3)
Ovarian Neoplasms (Phase 3)
Periodontitis (Phase 4)
Peritoneal Neoplasms (Phase 1)
Philadelphia Chromosome (Phase 2)
Pneumonia (Phase 4)
Preleukemia (Phase 2)
Psoriasis (Phase 2)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 3)
Retinal Diseases (Phase 3)
Retinal Vein Occlusion (Phase 3)
Rheumatic Fever (Phase 4)
Sarcoma (Phase 2)
Sclerosis (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 2)
Telangiectasis (Phase 4)
Urinary Tract Infections (Phase 4)